Bisimulations for weighted automata over an additively idempotent semiring N Damljanović, M Ćirić, J Ignjatović Theoretical computer science 534, 86-100, 2014 | 53 | 2014 |
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients V Otasevic, B Mihaljevic, N Milic, D Stanisavljevic, V Vukovic, K Tomic, ... Thrombosis Journal 20 (1), 20, 2022 | 11 | 2022 |
Biomarkers of hemostatic dysregulation and inflammation in lymphoma: potential relevance to thrombogenesis D Antic, N Milic, E Bontekoe, D Hoppensteadt, V Djurasinovic, V Vukovic, ... Blood 134, 4945, 2019 | 8 | 2019 |
Position paper on the management of pregnancy-associated superficial venous thrombosis. Balkan working group for prevention and treatment of venous thromboembolism D Antic, E Lefkou, V Otasevic, L Banfic, E Dimakakos, D Olinic, D Milić, ... Clinical and Applied Thrombosis/Hemostasis 28, 1076029620939181, 2022 | 7 | 2022 |
Expression of BCL11A in chronic lymphocytic leukaemia N Tosic, M Ugrin, I Marjanovic, T Kostic, V Vukovic, K Tomic, V Otasevic, ... International Journal of Laboratory Hematology 45 (1), 64-71, 2023 | 5 | 2023 |
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL D Antic, N Milic, T Chatzikonstantinou, L Scarfò, V Otasevic, N Rajovic, ... Journal of hematology & oncology 15 (1), 116, 2022 | 5 | 2022 |
Prognosis and new therapeutic approaches in chronic lymphocytic leukemia treatment V Otašević, B Mihaljević, D Antić Medicinski podmladak 70 (4), 6-12, 2019 | 2 | 2019 |
Throly Score Successfully Classifies Hodgkin Lymphoma Patients at Risk of Thromboembolic Complication D Antic, V Otasevic, S Borchmann, H Muller, V Vukovic, V Djurasinovic, ... Blood 136, 8, 2020 | 1 | 2020 |
Venous thromboembolic complications in lymphoma patients V Otašević, D Antić, B Mihaljević Medicinski podmladak 71 (4), 25-39, 2020 | 1 | 2020 |
PB2278 PRETREATMENT SERUM 25 (OH) VITAMIN D AS PREDICTOR OF EVENT-FREE SURVIVAL IN LYMPHOID MALIGNANCIES V Djurasinovic, B Mihaljevic, V Vukovic, D Antic, K Tomic, V Otasevic HemaSphere 3 (S1), 1018, 2019 | 1 | 2019 |
Primena softvera otvorenog koda kod vizualizacije podataka V Otašević, B Kosanović Računarski centar Universiteta u Beogradu, Beograd, Srbija ( file:///C …, 0 | 1 | |
Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia K Tomic Vujovic, M Ugrin, N Tosic, V Vukovic, I Marjanovic, T Kostic, ... International Journal of Molecular Sciences 25 (2), 922, 2024 | | 2024 |
Unique presentation of T-cell/histiocyte-rich large B cell lymphoma complicated with hemophagocytic lymphohistiocytosis: case report and review of the literature A Pešić, V Vuković, S Kozarac, V Otašević, T Bibić, B Mihaljević, D Antić Journal of Medical Biochemistry, 2024 | | 2024 |
Identifying Novel Coagulation Biomarkers for Thrombosis in Patients with Lymphoma D Antic, V Otasevic, O Mitrovic-Ajtic, D Djikic, E Zivkovic, T Dragojevic, ... Blood 142, 4023, 2023 | | 2023 |
Non-O Blood Group and Pretreatment Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma V Otasevic, J Ivanovic, V Vukovic, N Milic, S Kozarac, A Pesic, ... Blood 142, 5539, 2023 | | 2023 |
Biomarkeri inflamacije i ekstracelularne vezikule kao prediktori venske tromboembolije kod pacijenata sa limfomom V Otašević Универзитет у Београду, 2023 | | 2023 |
KOMPLEKSNI KARIOTIP U HRONIČNOJ LIMFOCITNOJ LEUKEMIJI-PREGLEDNI ČLANAK D Antić, S Kozarac, KT Vujovic, V Otasevic, A Pesic, V Vukovic, ... Medicinska istraživanja 56 (3), 2023 | | 2023 |
PB2662: ABO BLOOD GROUP TYPE AND RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA V Otasevic, J Ivanović, V Vukovic, S Sarac, B Mihaljevic, D Antic HemaSphere 7 (S3), e346044f, 2023 | | 2023 |
P1653: INFLAMMATION MEDIATED THROMBUS FORMATION IN LYMPHOMAS D Antic, OM Ajtić, D Djikić, V Otasevic, E Živković, J Ivanović, V Vuković, ... HemaSphere 7 (S3), e541657a, 2023 | | 2023 |
PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD V Vukovic, T Karan-Đurašević, P Tulic, D Antic, V Otasevic, S Sarac, ... HemaSphere 7 (S3), e273137e, 2023 | | 2023 |